Mechanisms of Epithelial-Mesenchymal Transition and Prevention of Dispase-Induced PVR by Delivery of an Antioxidant αB Crystallin Peptide

Proliferative Vitreoretinopathy (PVR) is a refractory retinal disease whose primary pathogenesis involves the epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. At present, there is no effective treatment other than surgery for PVR. The purpose of this study was to investigate the effect of αB crystallin peptide (αBC-P) on EMT in PVR. We have previously shown that this peptide is antiapoptotic and regulates RPE redox status. Subconfluent primary human RPE (hRPE) cells were stimulated by TGFβ2 (10 ng/mL) with or without αBC-P (50 or 75 μg/mL) for 48 h and expression of EMT/mesenchymal to epithelial transition (MET) markers was determined. Mitochondrial ROS (mtROS) generation in hRPE cells treated with TGFβ2 was analyzed. The effect of TGFβ2 and αBC-P on oxidative phosphorylation (OXPHOS) and glycolysis in hRPE was studied. RPE cell migration was also assessed. A PVR-like phenotype was induced by intravitreal dispase injection in C57BL/6J mice. PVR progression and potential therapeutic efficiency of αBC-Elastin-like polypeptides (ELP) was studied using fundus photography, OCT imaging, ERG, and histologic analysis of the retina. αSMA, E-cadherin, Vimentin, Fibronectin and, RPE65, and CTGF were analyzed on Day 28. Additionally, the amount of VEGF-A in retinal cell lysates was measured. The EMT-associated αSMA, Vimentin, SNAIL and SLUG showed a significant upregulation with TGFβ2, and their expression was significantly suppressed by cotreatment with αBC-P. The MET-associated markers, E-cadherin and Sirt1, were significantly downregulated by TGFβ2 and were restored by αBC-P. Incubation of hRPE with TGFβ2 for 24 h showed a marked increase in mitochondrial ROS which was noticeably inhibited by αBC-ELP. We also showed that after TGFβ2 treatment, SMAD4 translocated to mitochondria which was blocked by αBC-ELP. Mitochondrial oxygen consumption rate increased with TGFβ2 treatment for 48 h, and αBC-P co-treatment caused a further increase in OCR. Glycolytic functions of RPE were significantly suppressed with αBC-P (75 μg/mL). In addition, αBC-P significantly inhibited the migration from TGFβ2 treatment in hRPE cells. The formation of proliferative membranes was suppressed in the αBC-ELP-treated group, as evidenced by fundus, OCT, and H&E staining in dispase-induced PVR in mice. Furthermore, ERG showed an improvement in c-wave amplitude. In addition, immunostaining showed significant suppression of αSMA and RPE65 expression. It was also observed that αBC-ELP significantly reduced the expression level of vimentin, fibronectin, and CTGF. Our findings suggest that the antioxidant αBC-P may have therapeutic potential in preventing PVR by reversing the phenotype of EMT/MET and improving the mitochondrial function in RPE cells.

[1]  Shaoqiu He,et al.  BzATP Activates Satellite Glial Cells and Increases the Excitability of Dorsal Root Ganglia Neurons In Vivo , 2022, Cells.

[2]  S. Reddy,et al.  Mechanisms of RPE senescence and potential role of αB crystallin peptide as a senolytic agent in experimental AMD. , 2022, Experimental eye research.

[3]  C. Pérez-Novo,et al.  Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism , 2021, Frontiers in Pharmacology.

[4]  D. Ferrington,et al.  Glutathione Metabolism and the Novel Role of Mitochondrial GSH in Retinal Degeneration , 2021, Antioxidants.

[5]  S. Sadda,et al.  Transporter-Mediated Mitochondrial GSH Depletion Leading to Mitochondrial Dysfunction and Rescue with αB Crystallin Peptide in RPE Cells , 2020, Antioxidants.

[6]  Victor G. Puelles,et al.  Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS , 2020, EMBO reports.

[7]  A. Salminen,et al.  The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology , 2019, International journal of molecular sciences.

[8]  J. A. MacKay,et al.  Intra‐vitreal &agr;B crystallin fused to elastin‐like polypeptide provides neuroprotection in a mouse model of age‐related macular degeneration , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. M. van der Bliek,et al.  Cell Biology of the Mitochondrion , 2017, Genetics.

[10]  J. Linton,et al.  Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye , 2017, bioRxiv.

[11]  J. Al-Aama,et al.  The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages , 2016, The Journal of cell biology.

[12]  D. Hinton,et al.  αB-Crystallin Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition. , 2016, The American journal of pathology.

[13]  J. Pastor,et al.  Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences , 2016, Progress in Retinal and Eye Research.

[14]  D. Hinton,et al.  Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy , 2015, Scientific Reports.

[15]  L. Desai,et al.  Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis , 2015, Redox biology.

[16]  Shuai Yang,et al.  Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. , 2015, Discovery medicine.

[17]  Zhenna Chen,et al.  The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR , 2015, Molecular vision.

[18]  S. Mukai,et al.  Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy. , 2014, The American journal of pathology.

[19]  H. Cui,et al.  Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Mei Chen,et al.  Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse. , 2014, Translational vision science & technology.

[21]  J. Kopp,et al.  TGF-β1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway. , 2013, American journal of physiology. Renal physiology.

[22]  J. Garweg,et al.  Pathophysiology of proliferative vitreoretinopathy in retinal detachment. , 2013, Survey of ophthalmology.

[23]  Wencong Wang,et al.  The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice , 2013, International journal of nanomedicine.

[24]  V. Ganapathy,et al.  Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells. , 2013, Investigative ophthalmology & visual science.

[25]  P. Beer,et al.  ANALYSIS OF THE MOLECULAR BIOLOGIC MILIEU OF THE VITREOUS IN PROLIFERATIVE VITREORETINOPATHY , 2013, Retina.

[26]  Jing Yu,et al.  Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis. , 2012, Investigative ophthalmology & visual science.

[27]  D. Hinton,et al.  Novel roles for α-crystallins in retinal function and disease , 2012, Progress in Retinal and Eye Research.

[28]  S. Brownell,et al.  Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis* , 2012, The Journal of Biological Chemistry.

[29]  D. Hinton,et al.  Deficiency of αB crystallin augments ER stress-induced apoptosis by enhancing mitochondrial dysfunction. , 2012, Free radical biology & medicine.

[30]  Q. Gao,et al.  Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice , 2012, Molecular vision.

[31]  Y. Liu,et al.  Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy , 2012, Eye.

[32]  S. Cole,et al.  Mechanism of RPE Cell Death in α-Crystallin Deficient Mice: A Novel and Critical Role for MRP1-Mediated GSH Efflux , 2012, PloS one.

[33]  G. Reiser,et al.  Phosphorylation of Ser45 and Ser59 of αB‐crystallin and p38/extracellular regulated kinase activity determine αB‐crystallin‐mediated protection of rat brain astrocytes from C2‐ceramide‐ and staurosporine‐induced cell death , 2011, Journal of neurochemistry.

[34]  E. Barrón,et al.  αB Crystallin Is Apically Secreted within Exosomes by Polarized Human Retinal Pigment Epithelium and Provides Neuroprotection to Adjacent Cells , 2010, PloS one.

[35]  E. Wawrousek,et al.  alphaB-crystallin regulation of angiogenesis by modulation of VEGF. , 2010, Blood.

[36]  A. Doseff,et al.  The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity , 2010, Cell Death and Disease.

[37]  S. Kase,et al.  Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: Relevance to age-related macular degeneration , 2009, Aging.

[38]  You-xin Chen,et al.  Connective tissue growth factor as a mediator of intraocular fibrosis. , 2008, Investigative ophthalmology & visual science.

[39]  M. Bartoli,et al.  Vascular endothelial growth factor in eye disease , 2008, Progress in Retinal and Eye Research.

[40]  A. Suburo,et al.  Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. , 2008, The American journal of pathology.

[41]  E. Wawrousek,et al.  α-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress , 2007, Molecular vision.

[42]  D. Hinton,et al.  In vivo models of proliferative vitreoretinopathy , 2007, Nature Protocols.

[43]  J. Parel,et al.  Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract , 2006, Ophthalmologica.

[44]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[45]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[46]  A. Suburo,et al.  A mouse model of proliferative vitreoretinopathy induced by dispase. , 2002, Experimental eye research.

[47]  P. Khaw,et al.  Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. , 1999, Investigative ophthalmology & visual science.

[48]  J. D. Cameron,et al.  A new model of proliferative vitreoretinopathy. , 1998, Investigative ophthalmology & visual science.

[49]  M. Weller,et al.  Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. , 1997, Experimental eye research.

[50]  M. Sporn,et al.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. , 1989, The Journal of clinical investigation.

[51]  W. Walther,et al.  Real-Time Cell Migration Monitoring to Analyze Drug Synergism in the Scratch Assay Using the IncuCyte System. , 2021, Methods in molecular biology.

[52]  H. Kaplan,et al.  Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy. , 2016, Experimental eye research.

[53]  D. Hinton,et al.  Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degeneration. , 2016, Biochimica et biophysica acta.

[54]  Jonathan G. Rud,et al.  Nuclear targeting of transforming growth factor-beta-activated Smad complexes. , 2005, The Journal of biological chemistry.

[55]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[56]  A. Spector,et al.  What is alpha crystallin? , 1971, American journal of ophthalmology.